SARS-CoV-2 vaccination and myocarditis in a Nordic cohort study of 23 million residents
…, A Husby, T Härkänen, RM Selmer, N Pihlström… - JAMA …, 2022 - jamanetwork.com
Importance Reports of myocarditis after SARS-CoV-2 messenger RNA (mRNA) vaccination
have emerged. Objective To evaluate the risks of myocarditis and pericarditis following SARS…
have emerged. Objective To evaluate the risks of myocarditis and pericarditis following SARS…
Factors associated with neck and shoulder pain: a cross-sectional study among 16,000 adults in five county councils in Sweden
G Peterson, N Pihlström - BMC musculoskeletal disorders, 2021 - Springer
Background Neck and shoulder pain is common in the general population, but studies on
factors related to the risk of neck and shoulder pain have produced inconclusive results. …
factors related to the risk of neck and shoulder pain have produced inconclusive results. …
[HTML][HTML] Clinical outcomes of myocarditis after SARS-CoV-2 mRNA vaccination in four Nordic countries: population based cohort study
…, HL Gulseth, P Hovi, JV Hansen, N Pihlström… - BMJ …, 2023 - ncbi.nlm.nih.gov
… Anders Husby, corresponding author 1 Hanne Løvdal Gulseth, 2 Petteri Hovi, 3, 4 Jørgen
Vinsløv Hansen, 1 Nicklas Pihlström, 5 Nina Gunnes, 2 Tommi Härkänen, 6 Jesper Dahl, 7 …
Vinsløv Hansen, 1 Nicklas Pihlström, 5 Nina Gunnes, 2 Tommi Härkänen, 6 Jesper Dahl, 7 …
Comparative effectiveness of bivalent BA. 4-5 and BA. 1 mRNA booster vaccines among adults aged≥ 50 years in Nordic countries: nationwide cohort study
NW Andersson, EM Thiesson, U Baum, N Pihlström… - bmj, 2023 - bmj.com
Objective To estimate the effectiveness of the bivalent mRNA booster vaccines containing
the original SARS-CoV-2 and omicron BA.4-5 or BA.1 subvariants as the fourth dose against …
the original SARS-CoV-2 and omicron BA.4-5 or BA.1 subvariants as the fourth dose against …
Comparative effectiveness of heterologous third dose vaccine schedules against severe covid-19 during omicron predominance in Nordic countries: population based …
NW Andersson, EM Thiesson, U Baum, N Pihlström… - bmj, 2023 - bmj.com
Objective To investigate the comparative vaccine effectiveness of heterologous booster
schedules (ie, three vaccine doses) compared with primary schedules (two vaccine doses) and …
schedules (ie, three vaccine doses) compared with primary schedules (two vaccine doses) and …
[HTML][HTML] Validation of myocarditis diagnoses in the Swedish patient register for analyses of potential adverse reactions to COVID-19 vaccines
…, ML Nurminen, M Grünewald, N Pihlström… - Upsala Journal of …, 2023 - ncbi.nlm.nih.gov
Background Coronavirus disease 2019 (COVID-19) mRNA vaccines are associated with an
increased risk of myocarditis using hospital discharge diagnoses as an outcome. The …
increased risk of myocarditis using hospital discharge diagnoses as an outcome. The …
Booster vaccination with SARS-CoV-2 mRNA vaccines and myocarditis in adolescents and young adults: a Nordic cohort study
A Hviid, TA Nieminen, N Pihlström… - European Heart …, 2024 - academic.oup.com
Background and Aims The SARS-CoV-2 mRNA vaccines are associated with an increased
risk of myocarditis. This association appears to be strongest in male adolescents and …
risk of myocarditis. This association appears to be strongest in male adolescents and …
STAMP2 expression mediated by cytokines attenuates their growth-limiting effects in prostate cancer cells
Simple Summary Prostate cancer (PCa) is the most common non-skin cancer and one of the
leading causes of cancer death in men. Despite significant developments in therapy options …
leading causes of cancer death in men. Despite significant developments in therapy options …
Improved long-term outcome of patients with non-muscle invasive, low and intermediate risk bladder cancer between 1997 and 2014; a Swedish population-based …
EYH Wang, N Pihlström, PU Malmström… - … journal of urology, 2022 - Taylor & Francis
Objective The most common form of urinary bladder cancer is the low and intermediate risk
categories of stage Ta. This patient group has a high recurrence rate, but progression is rare. …
categories of stage Ta. This patient group has a high recurrence rate, but progression is rare. …
Booster Vaccination with SARS-CoV-2 mRNA Vaccines and Myocarditis Risk in Adolescents and Young Adults: A Nordic Cohort Study of 8.9 Million Residents
A Hviid, TA Nieminen, N Pihlström, N Gunnes, J Dahl… - medRxiv, 2022 - medrxiv.org
Importance The SARS-CoV-2 mRNA vaccines are associated with an increased risk of
myocarditis. This association appears to be strongest in male adolescents and younger males …
myocarditis. This association appears to be strongest in male adolescents and younger males …
